ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 434 filers reported holding ENCOMPASS HEALTH CORP in Q4 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,257 | -80.8% | 14,649 | -81.5% | 0.01% | -82.0% |
| Q1 2024 | $6,541 | +907.9% | 79,213 | +719.8% | 0.05% | +733.3% |
| Q3 2023 | $649 | -79.0% | 9,663 | -83.1% | 0.01% | -76.9% |
| Q1 2023 | $3,090 | -98.5% | 57,117 | +1495.9% | 0.03% | +1200.0% |
| Q2 2022 | $201,000 | -46.7% | 3,579 | -32.5% | 0.00% | -60.0% |
| Q1 2022 | $377,000 | -79.0% | 5,299 | -80.7% | 0.01% | -73.7% |
| Q4 2021 | $1,792,000 | -84.2% | 27,456 | -81.9% | 0.02% | -87.6% |
| Q3 2021 | $11,356,000 | +198.4% | 151,297 | +210.2% | 0.15% | +264.3% |
| Q2 2021 | $3,806,000 | +185.7% | 48,776 | +202.9% | 0.04% | +223.1% |
| Q4 2020 | $1,332,000 | +156.2% | 16,104 | +101.3% | 0.01% | +30.0% |
| Q3 2020 | $520,000 | -78.4% | 7,999 | -79.4% | 0.01% | -83.9% |
| Q2 2020 | $2,403,000 | +128.0% | 38,802 | +155.0% | 0.06% | +210.0% |
| Q4 2019 | $1,054,000 | – | 15,215 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 697,659 | $45,334,000 | 10.13% |
| JANA PARTNERS LLC | 1,741,513 | $113,164,000 | 10.12% |
| Endurant Capital Management LP | 276,105 | $17,941,000 | 5.31% |
| REINHART PARTNERS, LLC. | 726,140 | $47,184,000 | 3.55% |
| Prosight Management, LP | 107,921 | $7,013,000 | 3.34% |
| Advantage Alpha Capital Partners LP | 160,234 | $10,412,000 | 2.41% |
| RK Capital | 115,800 | $7,525,000 | 2.13% |
| Copeland Capital Management, LLC | 700,015 | $45,487,000 | 2.02% |
| Sivik Global Healthcare LLC | 65,000 | $4,224,000 | 1.82% |
| Walthausen & Co., LLC | 120,016 | $7,799,000 | 1.62% |